Alemtuzumab for treatment of B-cell chronic lymphocytic leukaemia: Rapid Review
Alemtuzumab (MabCampath®): Review by the South Australian Medicines Evaluation Panel
Alemtuzumab (MabCampath®): Review by the South Australian Medicines Evaluation Panel